PARTNERSHIP AND INNOVATION IN THE LIFE SCIENCES - Innovation in the Biopharmaceutical Industry - page 131

FDA (2004). Innovation — innovation stagnation: challenge and opportunity on the crit-
ical path to new medical products. Available at URL: http://www.fda.gov/oc/ initia-
tives/criticalpath/whitepaper.pdf.
Fiol, CM (1996). Introduction to the special topic forum: squeezing harder doesn't always
work: continuing the search for consistency in innovation research. The Academy of
Management Review , 21(4), 1012-1021.
Gambardella, A, L Orsenigo and F Pammoli (2000). Global competitiveness in pharmaceuti-
cals — a European perspective. Report prepared for the Enterprise Directorate-General
of the European Commission.
Granstrand, O, P Patel and K Pavitt (1997). Multi-technology corporations: why they
have “distributed” rather than “distinctive core” competencies. California Manage-
ment Review , 39(4), 8-25.
Hargadon, A (2003). How Breakthroughs Happen . Boston: Harvard Business School Pub-
lishing Corporation.
Hargadon, A and R Sutton (1997). Technology brokering and innovation in a product
development firm. Administrative Science Quarterly , 42(4), 716-749.
Henderson, R, A Jaffe and M Trajtenberg (1994). Universities as a Source of Commercial
Technology : A Detailed Analysis of University patenting, 1965-1988. Cambridge MA:
National Bureau of Economic Research (Working Paper No. 5068).
HITF (2004). Better healthcare through partnership: A programme for action. Report of the
Health Industry Task Force co-chaired by Lord Warner and Sir Christopher O'Donnell.
Available at URL: http://www.dti.go.uk.
Jaffe, AB (1986). Technological opportunity and spillovers of R&D: evidence from firms'
patents, profits and market value. American Economic Review , 76, 984-1001.
Jaffe, AB (1996). Trends and patterns in research and development expenditures in the
United States. Proceedings of the National Academy of Sciences of the United States
of America , 93(23), 12658-12663.
James, BG (1994). The pharmaceutical industry in 2000: reinventing the pharmaceutical
company. The Economist Intelligence Unit .
Kamien, MI and I Zang (2000). Meet me halfway: research joint ventures and absorptive
capacity. International Journal of Industrial Organization , 18(7), 995-1012.
Kline, JJ (2000). Research joint ventures and the cost paradox. International Journal of
Industrial Organization , 18(7), 1049-1065.
Krishnan, V and KT Ulrich (2001). Product development decisions: a review of the literature.
Management Science , 47 (1), 1-21.
Lambert, R (2003). Lambert Review of Business-University Collaboration . London: HM
Treasury. Available at URL: http://www.lambertreview.org.uk.
Lamoreaux, NR and KL Sokoloff (1996). Long-term change in the organization of inventive
activity. Proceedings of the National Academy of Sciences of the United States of
America , 93(23), 12686-12692.
Mays, N and C Pope (1995). Rigour and qualitative research. British Medical Journal , 311,
109-12.